Approval · Notice of Compliance 11349 · 2010

SAIZEN: Notice of Compliance 11349

Issued April 29, 2010

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 11349
Date: April 29, 2010
Company: Emd Canada Inc
Product type: Biologic
Submission: Supplement to a New Drug Submission (SNDS), supplement
Submission class: Other
Reason: New liquid formulation
Therapeutic class: Human growth hormone

Products in this notice

Brand	DIN	Status today
SAIZEN	02350122	Marketed
SAIZEN	02350130	Marketed
SAIZEN	02350149	Marketed

Medicinal ingredients

SOMATROPIN 6 MG per CART
SOMATROPIN 12 MG per CART
SOMATROPIN 20 MG per CART